Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligon... Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligonucleotide Conjugates (AOCs) platform to create transformative healthcare solutions. This platform combines antibodies and oligonucleotides to precisely target and deliver therapeutic payloads to specific diseased cells, potentially advancing treatments for a range of genetic disorders. The company's research primarily impacts sectors such as rare disease treatment and genetic medicine, where precision and efficacy are critical. By leveraging its unique technology, Avidity Biosciences plays a significant role in the biotechnology landscape, fostering advancements that seek to alter the genetic disease treatment paradigm and improve patient outcomes globally.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by Avidity Biosciences

We reviewed Avidity Biosciences's website and available disclosure materials for the 2023 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Avidity Biosciences's data?

Create a free Tracenable account to signal interest in having our team review data for Avidity Biosciences.

Legal Center Contact Us